{
    "drug": "Dostarlimab",
    "sponsor": "GlaxoSmithKlien",
    "searchResults": [
        {
            "url": "https://www.ema.europa.eu/en/documents/product-information/jemperli-epar-product-information_en.pdf",
            "title": "Jemperli, INN-dostarlimab",
            "ID": "",
            "drugSentence": "",
            "indication": "",
            "sponsorSentence": "",
            "extracts": [
                {
                    "type": "formulationsAndExcipients",
                    "data": [
                        "LIST OF EXCIPIENTS\nExcipients: trisodium citrate dihydrate; citric acid monohydrate; L-arginine hydrochloride; sodium\nchloride; polysorbate 80; water for injection."
                    ],
                    "url": "https://www.ema.europa.eu/en/documents/product-information/jemperli-epar-product-information_en.pdf",
                    "file": "jemperli-epar-product-information_en.pdf"
                }
            ]
        },
        {
            "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf",
            "title": "This label may not be the latest approved by FDA. For current ...",
            "ID": "",
            "drugSentence": "",
            "indication": "",
            "sponsorSentence": "",
            "extracts": [
                {
                    "type": "formulationsAndExcipients",
                    "data": [
                        "Each mL of solution contains\n50 mg of dostarlimab-gxly, citric acid monohydrate (0.48 mg), L-arginine hydrochloride\n(21.07 mg), polysorbate 80 (0.2 mg), sodium chloride (1.81 mg), trisodium citrate dihydrate\n(6.68 mg), and Water for Injection, USP.",
                        "Active ingredient: dostarlimab-gxly\nInactive ingredients: citric acid monohydrate, L-arginine hydrochloride, polysorbate 80, sodium\nchloride, trisodium citrate dihydrate, and Water for Injection."
                    ],
                    "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf",
                    "file": "761174s000lbl.pdf"
                },
                {
                    "type": "excipQuantComposition",
                    "data": [
                        "Each mL of solution contains\n50 mg of dostarlimab-gxly, citric acid monohydrate (0.48 mg), L-arginine hydrochloride\n(21.07 mg), polysorbate 80 (0.2 mg), sodium chloride (1.81 mg), trisodium citrate dihydrate\n(6.68 mg), and Water for Injection, USP."
                    ],
                    "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761174s000lbl.pdf",
                    "file": "761174s000lbl.pdf"
                }
            ]
        },
        {
            "source": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?label=all&query=Dostarlimab",
            "searchCriteriaDosage": false,
            "searchCriteriaRegimen": false,
            "title": "View Package Photos",
            "extracts": [
                {
                    "type": "formulationsAndExcipients",
                    "data": [
                        "Each mL of solution contains 50 mg of dostarlimab-gxly, citric acid monohydrate (0.48 mg), L-arginine hydrochloride (21.07 mg), polysorbate 80 (0.2 mg), sodium chloride (1.81 mg), trisodium citrate dihydrate (6.68 mg), and Water for Injection, USP.",
                        "Active ingredient: dostarlimab-gxly Inactive ingredients : citric acid monohydrate, L-arginine hydrochloride, polysorbate 80, sodium chloride, trisodium citrate dihydrate, and Water for Injection."
                    ]
                },
                {
                    "type": "excipQuantComposition",
                    "data": [
                        "Each mL of solution contains 50 mg of dostarlimab-gxly, citric acid monohydrate (0.48 mg), L-arginine hydrochloride (21.07 mg), polysorbate 80 (0.2 mg), sodium chloride (1.81 mg), trisodium citrate dihydrate (6.68 mg), and Water for Injection, USP."
                    ]
                }
            ],
            "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?label=all&query=Dostarlimab",
            "ID": "NCT03981796",
            "extractPDFs": [],
            "indication": "",
            "drugSentence": "Label: JEMPERLI- dostarlimab injection Label RSS View Package Photos Drug Label Info Safety Report Adverse Events FDA Safety Recalls Presence in Breast Milk Related Resources Medline Plus Clinical Trials PubMed All"
        }
    ]
}